- Naphazoline nitrate
-
- $0.00 / 1kg
-
2023-11-01
- CAS:5144-52-5
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
- Naphazoline nitrate
-
- $0.00 / 25KG
-
2023-09-06
- CAS:5144-52-5
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Naphazoline nitrate
-
- $50.00 / 1kg
-
2023-06-30
- CAS:5144-52-5
- Min. Order: 1kg
- Purity: 99.9%
- Supply Ability: 10000MT
|
| | Naphazoline nitrate Basic information |
| Product Name: | Naphazoline nitrate | | Synonyms: | NAPHAZOLINE NITRATE;NAPHAZOLINE NITRATE SALT;NAPHAZOLINI NITRAS;LABOTEST-BB LT00134653;2-(1-NAPHTHYLMETHYL)IMIDAZOLINIUM NITRATE;2-(1-NAPHTHYLMETHYL)IMIDAZOLINE NITRATE;2-[1-NAPHTHYLMETHYL]IMIDAZOLINE NITRATE SALT;2-(1-NAPHTHYLMETHYL)-2-IMIDAZOLINE NITRATE | | CAS: | 5144-52-5 | | MF: | C14H15N3O3 | | MW: | 273.29 | | EINECS: | 225-915-4 | | Product Categories: | API | | Mol File: | 5144-52-5.mol |  |
| | Naphazoline nitrate Chemical Properties |
| Melting point | 167-170 °C | | solubility | Sparingly soluble in water, soluble in ethanol (96 per cent). | | Sensitive | Hygroscopic | | BRN | 3779329 | | InChIKey | ZAHXYMFVNNUHCP-UHFFFAOYSA-N | | CAS DataBase Reference | 5144-52-5(CAS DataBase Reference) |
| Hazard Codes | Xn | | Risk Statements | 22 | | Safety Statements | 22-36/37-60-36 | | RIDADR | 3249 | | WGK Germany | 3 | | RTECS | NJ4376000 | | F | 3-10 | | HazardClass | 6.1(b) | | PackingGroup | III | | HS Code | 29332900 |
| | Naphazoline nitrate Usage And Synthesis |
| Chemical Properties | White or almost white, crystalline powder. | | Uses | antihistamine | | Definition | ChEBI: Naphazoline nitrate is a member of naphthalenes. | | Indications | Naphazoline hydrochloride and naphazoline nitrate are white or almost white crystalline powders soluble 1 in 6 and 1 in 36 water, respectively. These are potent sympathomimetic vasoconstrictors with a direct alpha-adrenergic receptor stimulatory action, and may be used as topical decongestants in 0.05% or 0.1% eyedrops. Frequent application of these solutions will produce a reactive hyperaemia. Instillation should not be repeated in less than 4-6 hours to avoid this rebound congestion.
Naphazoline eyedrops cause slight mydriasis and are contra-indicated in patients with actual or suspected closed-angle glaucoma.
Although not administered systemically, topical application of naphazoline has resulted in systemic absorption, and it is readily absorbed from the gastro-intestinal tract (Martindale, 1977). |
| | Naphazoline nitrate Preparation Products And Raw materials |
|